In-person tickets are SOLD OUT. Join waitlist. Voting members who wish to attend, please email mwightwick@biomelbourne.org. We invite colleagues from our…
FIND OUT MOREFor a more in-depth look at this topic, take a deep-dive into our Masterclass program – Vital Ventures: Scaling Healthtech…
FIND OUT MOREScaling a healthtech business – whether a start-up or established venture - requires more than just a groundbreaking idea. For…
FIND OUT MOREPosted: 20 November 2024 Dimerix Limited (ASX: DXB) a biopharmaceutical company with late-stage clinical assets in inflammatory diseases, today confirmed…
READ MOREPosted: 20 November 2024 The Company Our client is a leading Australian-owned Clinical Research Organisation specialising in end-to-end services for…
READ MOREPosted: 20 November 2024 ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as…
READ MORE